Results 71 to 80 of about 2,399 (178)

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia

open access: yesVascular Health and Risk Management, 2014
Alpo Vuorio,1,2 Matti J Tikkanen,3 Petri T Kovanen4 1Health Center Mehiläinen, Vantaa, Finland; 2Finnish Institute of Occupational Health, Lappeenranta, Finland; 3Heart and Lung Center, Helsinki University Central Hospital, Folkhälsan Research ...
Vuorio A, Tikkanen MJ, Kovanen PT
doaj  

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

open access: yesMedical Devices: Evidence and Research, 2016
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation ...
Julius U
doaj  

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia. [PDF]

open access: yesLipids Health Dis, 2016
Varga VE   +7 more
europepmc   +1 more source

LDL-apheresis.

open access: yesJinko Zoki, 1986
YOKOYAMA, S.   +3 more
openaire   +1 more source

Three decades of experience with therapeutic apheresis at a tertiary academic center: review of indications, clinical practice, special age groups and complications. [PDF]

open access: yesBMC Nephrol
Jerman A   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy